LifeStance Health vs P3 Health Partners
LFST and PIII side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LFST and PIII compare
LifeStance Health is the larger company, worth 274 times as much as P3 Health Partners ($5.4B against $19.6M).
LifeStance Health grew revenue faster over the last twelve months (22.6% versus 7.5% for P3 Health Partners).
LifeStance Health keeps more of each dollar of sales as profit, with a net margin of 4.3% compared with −3.3% at P3 Health Partners.
LifeStance Health scores higher on the StockData Score (12 against 4 for P3 Health Partners), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LFST | PIII |
|---|---|---|
| Size and price | ||
| Market cap | $5.4B | $19.6M |
| Share price | $14.08 | $2.70 |
| Change, 1 year | 119% | −64.6% |
| Change, 5 years | 62.8% | −99.5% |
| Beta (5Y) | 1.17 | 1.16 |
| Employees | 11K | 320 |
| StockData Score | ||
| Total score | 12 (better) | 4 |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 (better) | 1 |
| Performance score | 3 (better) | 2 |
| Health score | 6 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 74.1× | – |
| P/S | 3.2× | 0.0× (better) |
| P/B | 3.6× | – |
| EV/EBITDA | 36.7× (better) | 36.9× |
| P/FCF | 30.0× | – |
| FCF yield | 3.3% | – |
| Fair value | $5.88 | – |
| Margin of safety | −139% | – |
| Growth | ||
| Revenue growth (TTM) | 22.6% (better) | 7.5% |
| Revenue growth, 5Y average | – | 24.3% |
| Profitability | ||
| Operating margin | 6.2% (better) | −5.2% |
| Net margin | 4.3% (better) | −3.3% |
| FCF margin | 10.7% | – |
| Return on equity | 4.8% | – |
| Return on invested capital | 5.4% (better) | −32.7% |
| Financial health | ||
| Debt / equity | 0.18 | – |
| Net debt / EBITDA | 0.35 (better) | 28.58 |
| Interest coverage | 10.6× | – |
| Current ratio | 1.44 (better) | 0.53 |
| Altman Z-score | 5.16 (better) | 0.29 |
| Piotroski F-score | 7 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 98.7% | 65.0% |
| Held by insiders | 64.6% | 98.0% |
| Insider net buying, 12 months | −$849M | −$824K (better) |
| Short interest, % of float | 10.1% | – |
Go deeper
- LFST stock overview
- LFST income statement
- LFST valuation and score
- PIII stock overview
- PIII income statement
- PIII valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.